Patent · US Active

Modified FGF-21 polypeptides and their uses

US8012931B2 · kind B2 · utility

65Cited by
165References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2008
Grant dateSep 6, 2011
Priority date—
Expiry dateMar 19, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified FGF-21 polypeptides and uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.